Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 28 ... for therapeutic application to the eye, including age-related macular degeneration, diabetic macular edema, glaucoma, dry eye and uveitis. Substantially all of the employees of ... that bolster our total research platform in support of innovative products to treat eye disease," said Kevin Buehler, Alcon's president and chief executive officer. "We welcome Dr. ...
2009 NOV 2 ... in this category include DES, age-related macular degeneration (AMD) and proliferative diabetic retinopathy (PDR). According to Business Insights, the ophthalmic pharmaceutical market ... application of the company's breakthrough wound care technology to the treatment of dry eye syndrome (DES) with the Auxano point-of-care indicator system. Dry eye syndrome (DES) is ... is a condition that affects millions of people worldwide. According to the Centers for Disease Control (CDC), DES can be a serious condition, which, if left untreated, can damage ...
2009 NOV 9 ... on a clinical trial showing that the steroid triamcinolone may be effective in advanced diabetic macular edema (DME) patients when standard treatment fails, and on the public's use of ... Benefits AMD Patients; Steroid Drug May Restore Vision in DME Patients; Top Online Eye Health Forums Analyzed Highlights of November 2009 "Ophthalmology" SAN ... to benefit patients with age-related macular degeneration (AMD) at all stages of the disease, on a clinical trial showing that the steroid triamcinolone may be effective in advanced ...
2009 NOV 1 ... and intensive glucose control on the incidence and progression of retinopathy in type 2 diabetic patients. The Action in Diabetes and Vascular Disease: Preterax and Diamicron MR ... steps in the Early Treatment of Diabetic Retinopathy Study classification (using the eye with worst grading) was the primary outcome. Retinopathy progressed in 59 (4.8%) ...
2009 NOV 9 ... our knowledge of early microcirculatory alterations in prediabetes, diabetes, and diabetic micro- and macrovascular complications. Data from recent population-based studies ... For additional information, contact T.Y. Wong, University of Melbourne, Center Eye Research Australia, 32 Gisborne St., Melbourne, Vic 3002, Australia. The ... narrowing, for example, is associated with risk of diabetes and coronary artery disease, whereas retinal venular widening is associated with development and progression of ...
2009 OCT 12 ... in the United States. These studies, which are evaluating Perceiva as a treatment for diabetic macular edema (DME), neovascular (wet) age-related macular degeneration (wet AMD) and ... edema (DME), neovascular (wet) age-related macular degeneration (wet AMD) and dry eye syndrome, are part of MacuSight's broad Phase 2 Perceiva clinical program which spans ... of MacuSight's broad Phase 2 Perceiva clinical program which spans five major ocular disease indications. "The completion of enrollment in these important clinical ...
2009 NOV 2 ... for Perceiva, the company's proprietary ocular sirolimus product, for the treatment of diabetic macular edema (DME). MacuSight is currently advancing Perceiva in a broad Phase 2 ... treatment for DME, neovascular (wet) age-related macular degeneration (wet AMD) and dry eye syndrome. The company plans to announce data from these studies in the first half of ... injection provide the first evidence for the potential of treating retinal disease without direct injection into the back of the eye. Keywords: Age-Related ...
2009 NOV 16 ... type 2 diabetes. ACTOplus met is not for patients with type 1 "juvenile" diabetes or diabetic ketoacidosis. ACTOplus met has not been studied in children and is not recommended for ... or planning to breastfeed. Patients with diabetes should have regular eye exams. If they experience vision problems, consult a doctor immediately. Some patients ... in people with kidney problems, ACTOplus met should not be used in people with kidney disease or in people 80 years of age or older whose kidneys do not work properly. ...
2009 NOV 23 ... the vascular pattern of normal patients with mild to moderate non-proliferative diabetic retinopathy (NPDR), found a significant difference between them only in the macular ... employed as a useful parameter in the diagnosis of retinal disease. Avakian et al. (Curr Eye Res 2002; 24: 274-280), comparing the vascular pattern of normal patients with mild to ...
2009 OCT 19 ... may be decreasing for several reasons," Dr. Klein said. "Effective treatments for diabetic retinopathy (DR) and related macular edema became widely available in the 1970s, and ... loss than those diagnosed in earlier years, says a new study funded by the National Eye Institute, a division of the National Institutes of Health. Forecasts of visual ... from 1975 through 1979. Signs of Macular Degeneration May Predict Heart Disease A large study found strong evidence that older people who have age-related macular ...
2009 OCT 12 ... extended release intravitreal insert currently under development for the treatment of Diabetic Macular Edema (DME). Each Iluvien insert is designed to provide a sustained therapeutic ... FDA for the long-term, sustained release delivery of drug to treat chronic back of the eyedisease, reported the interim 18-month safety and efficacy results from the first human ...
2009 SEP 28 ... cause of blindness in a wide range of prevalent ocular diseases including proliferative diabetic retinopathy, exudative age-related macular degeneration, and retinopathy of prematurity, ... contact P.L. Gehlbach, Johns Hopkins University, School Medical, Retina Division, Wilmer Eye Institute, Dept. of Ophthalmology, 1550 Orleans St., Baltimore, MD 21231, USA. ... "The results demonstrate potential for therapeutic application in prevalent ocular disease. (Invest Ophthalmol Vis Sci. 2009; 50: 3840-3845) DOI: 10.1167/iovs.08-2607'." ...
2009 SEP 28 ... Even in common types of blindness such as age-related macular degeneration and diabetic retinopathy, vision could potentially be rescued by targeting cone cells, he said. ... to photopigments and make use of it almost instantaneously." Keywords: Eye Disorders, Asia, China, Computers, India, Pediatrics, Psychology, Technology, ... color blindness is only moderately life-altering, we've shown we can cure a cone disease in a primate, and that it can be done very safely. That's extremely encouraging for the ...
2009 NOV 17 ... diagnostic and treatment methods for many eye conditions such as cataracts, glaucoma, diabetic eye disease, and macular degeneration, as well as offering LASIK surgery procedures. For more ...
2009 NOV 16 ... 12 month period. In El Paso, persistence was the lowest in (56%) for non-insulin anti-diabetic medications at Month 12, compared to San Antonio where persistence was highest at Month ... medical care for Type 2 diabetes patients, such as A1c tests, cholesterol tests and eye exams, Texas continues to rank lower than the national averages. Only Austin exceeded ... indirectly related to diabetes, such as congestive heart failure, coronary artery disease, hypertension, hyperlipidemia and obesity. Diabetes care in Texas costs ...
2009 SEP 28 ... 12 month period. In El Paso, persistence was the lowest in (56%) for non-insulin anti-diabetic medications at Month 12, compared to San Antonio where persistence was highest at Month ... medical care for Type 2 diabetes patients, such as A1c tests, cholesterol tests and eye exams, Texas continues to rank lower than the national averages. Only Austin exceeded ... indirectly related to diabetes, such as congestive heart failure, coronary artery disease, hypertension, hyperlipidemia and obesity. Diabetes care in Texas costs ...
2009 NOV 9 ... veterans scored lower than norms for patients with glaucoma, multiple sclerosis (MS) and diabetic eye disease. On the NOS the veterans' scores were significantly lower than norms for patients with ...
2009 NOV 9 ... been increasingly able to reduce or cure ROP by adapting treatments developed for adult diabetic retinopathy. In the extremely premature infants saved today, though, all treatment ... MD, Columbia University School of Medicine, discussing the ever-tougher challenges Eye M.D.s face in caring for the vision of the tiniest premature babies; and a report by ... healthcare challenges, including retinopathy of prematurity (ROP) a potentially blinding disease. ROP is more likely to occur in such tiny infants and to be severe and hard to treat ...
2009 SEP 21 ... and Trademark Office ("USPTO") for a proprietary methodology in the treatment for Diabetic Retinopathy. The patent application was published by the USPTO on August 27th of this ... method for treating diabetic retinopathy and other degenerative conditions of the eye," said Nikolai Tankovich, MD, PhD, Stemedica's President and Chief Medical Officer. ... study provide new hope for the thousands of patients suffering from the debilitating disease of Diabetic Retinopathy." Stemedica's invention relates to the use of ...
